–
[연합뉴스TV 제공]
–
(Sejong = Yonhap News) Reporter Chae Yeon = JW New Drug, which provided rebates worth KRW 800 million to 90 hospitals and clinics[067290]It announced on the 7th that it has decided to impose a correction order and a penalty of 240 million won.
According to the Fair Trade Commission, JW New Drug, which handles 18 types of obesity treatments such as Pentermy, gave rebates worth about 800 million won to 90 hospitals and clinics nationwide to increase its prescriptions for obesity treatments from January 2014 to April 2017.
A certain amount of obesity treatment prescription was signed with hospitals and clinics, and in return, cash and goods equivalent to 20-35% of the contracted amount were handed over in advance.
After the rebate was provided, it was found that the’follow-up management’ was also carried out by checking whether the hospital or clinic prescribed the obesity treatment according to the contract, and reducing the support when the drug was not prescribed according to the contract.
<저작권자(c) 연합뉴스,
Unauthorized reproduction-redistribution prohibited>
2021/02/07 12:00 sent
–
